Results 61 to 70 of about 1,052 (92)

Study on PD-1 inhibitor combined with recombinant human endostatin and chemotherapy followed by IMRT in the treatment of advanced NSCLC. [PDF]

Medicine (Baltimore)
Ma F, Qi Z, Liao G, Zhao L, Su X, Dong C, Lu F, Sun Y.   +7 more
europepmc   +1 more source

Heparan Sulfate Proteoglycans: Master Regulators of Cellular Signaling, Tissue Development, and Neural Function. [PDF]

J Neurosci Res
Melrose J.
europepmc   +1 more source

The Role of Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in the Tumor Microenvironment and Their Impact on Ovarian Cancer Survival and Therapy. [PDF]

Curr Oncol
McQuarter AA, Cruz J, Yamauchi CR, Chouchen M, Carter CS, Webb TJ, Khan S.   +6 more
europepmc   +1 more source

Hybrid regulatory T cells: camouflaged architects of tumor immunity. [PDF]

Front Immunol
Azimnasab-Sorkhabi P, Soltani-Asl M, Kfoury Junior JR, Ansa-Addo EA.   +3 more
europepmc   +1 more source

HIF-PH inhibitors induce pseudohypoxia in T cells and suppress the growth of microsatellite stable colorectal cancer by enhancing antitumor immune responses. [PDF]

Cancer Immunol Immunother
Chen Y, Ohara T, Hamada Y, Wang Y, Tian M, Noma K, Tazawa H, Fujisawa M, Yoshimura T, Matsukawa A.   +9 more
europepmc   +1 more source

CD318 expression defines a novel subset of human CD8⁺ regulatory T cells. [PDF]

Sci Adv
Do JS, Chen WK, Hung YW, Arribas-Layton D, Lu C, Gu A, Montero E, Carmo AM, Reijonen H.   +8 more
europepmc   +1 more source

A Literature Review of Interleukins in the Development and Treatment of Breast Cancer. [PDF]

Int J Mol Sci
Kraśnicka W, Rybak N, Wójcik K, Stasiak A, Białowąs M, Grzegorczyk K, Kolenda T, Malicki J, Marszałek A, Janiczek-Polewska M.   +9 more
europepmc   +1 more source

CD28-driven ex vivo generation of stem-like memory CD8⁺ T cells bypassing CD3/TCR signaling. [PDF]

Proc Natl Acad Sci U S A
Ihara F, Ohashi Y, Zheng EYF, Fukao S, Rodrigo R, Noamani B, Boukhaled GM, Wang BX, Han DH, Wei X, Burt BD, Saso K, Matsunaga Y, Ly D, Kagoya Y, Butler MO, Mak TW, Saibil SD, Hirano N.   +18 more
europepmc   +1 more source

Normalizing the Tumor Microenvironment: A New Frontier in Ovarian Cancer Therapy. [PDF]

Int J Mol Sci
Jones AP, Zhao Y, Rueda BR, Yeku OO, Xu L.   +4 more
europepmc   +1 more source